Page 165 - Read Online

carcinoma (JIS score 0/1) improves survival. Ann Oncol 2014;25:1379-84. Arch Surg 1993;128:565-9.
17. Ishikawa T, Kubota T, Horigome R, Kimura N, Honda H, Iwanaga A, 20. He S, He F. Predictive model of portal venous system thrombosis in
Seki K, Honma T, Yoshida T. Concurrent partial splenic embolization with cirrhotic portal hypertensive patients after splenectomy. Int J Clin Exp
transcatheter arterial chemoembolization for hepatocellular carcinoma Med 2015;8:4236-42.
can maintain hepatic functional reserve. Hepatol Res 2014;44:1056-61. 21. Li MX, Zhang XF, Liu ZW, Lv Y. Risk factors and clinical characteristics
18. Ishikawa T, Kubota T, Horigome R, Kimura N, Honda H, Iwanaga A, of portal vein thrombosis after splenectomy in patients with liver
Seki K, Honma T, Yoshida T. Prevalence of Howell-Jolly bodies caused cirrhosis. Hepatobiliary Pancreat Dis Int 2013;12:512-9.
by partial splenic embolization for portal hypertension. Intern Med 22. Cai M, Zhu K, Huang W, Meng X, He K, Zhou B, Guo Y, Chen J,
2013;52:1765-8. Shan H. Portal vein thrombosis after partial splenic embolization in liver
19. Rattner DW, Ellman L, Warshaw AL. Portal vein thrombosis after cirrhosis: effi cacy of anticoagulation and long-term follow-up. J Vasc
elective splenectomy. An underappreciated, potentially lethal syndrome. Interv Radiol 2013;24:1808-16.

158 Hepatoma Research | Volume 1 | Issue 3 | October 15, 2015